AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 253: H704-H708, 1987;
0363-6135/87 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imaizumi, Y.
Right arrow Articles by Giles, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imaizumi, Y.
Right arrow Articles by Giles, W. R.

AJP - Heart and Circulatory Physiology, Vol 253, Issue 3 704-H708, Copyright © 1987 by American Physiological Society

ARTICLES

Quinidine-induced inhibition of transient outward current in cardiac muscle

Y. Imaizumi and W. R. Giles

Quinidine is frequently used as a class I antiarrhythmic agent in the management of cardiac rhythm disturbances. It depresses the rapid initial depolarization of the action potential by blocking the sodium current, INa. In addition, quinidine increases the duration of the action potential and lengthens the refractory period. We have used a whole cell voltage-clamp technique to study the ionic mechanism underlying the lengthening of the action potential in single cells from the atrium and ventricle of the rabbit heart. Our data show that quinidine at therapeutic doses (3-10 microM) is a potent and selective inhibitor of a transient outward current, which controls the early repolarization of the action potential. In contrast, neither the calcium current, ICa, nor the time-independent background K+ current, IK1, is changed significantly by 10 microM quinidine. The reduction in the transient outward current can explain the lengthening of action potential and provides new insight into the mechanism of action of quinidine as an antiarrhythmic agent.


This article has been cited by other articles:


Home page
 J. Neurophysiol.Home page
K. Aoki, K. Kosakai, and M. Yoshino
Monoaminergic Modulation of the Na+-Activated K+ Channel in Kenyon Cells Isolated From the Mushroom Body of the Cricket (Gryllus bimaculatus) Brain
J Neurophysiol, September 1, 2008; 100(3): 1211 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G.-X. Yan and C. Antzelevitch
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation
Circulation, October 12, 1999; 100(15): 1660 - 1666.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. M. Shuba, Y. Kasamaki, S. E. Jones, T. Ogura, J. R. McCullough, and T. F. McDonald
Action Potentials, Contraction, and Membrane Currents in Guinea Pig Ventricular Preparations Treated with the Antispasmodic Agent Terodiline
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1417 - 1426.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
N. I. Nenov, W. J. Crumb Jr, J. D. Pigott, L. H. Harrison Jr, and C. W. Clarkson
Quinidine Interactions With Human Atrial Potassium Channels : Developmental Aspects
Circ. Res., December 14, 1998; 83(12): 1224 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Zhang, B. Zhu, J.-A. Yao, and G.-N. Tseng
Differential Effects of S6 Mutations on Binding of Quinidine and 4-Aminopyridine to Rat Isoform of Kv1.4: Common Site but Different Factors in Determining Blockers' Binding Affinity
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 332 - 343.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G.-R. Li, J. Feng, L. Yue, and M. Carrier
Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H369 - H377.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. A. Sosunov, E. P. Anyukhovsky, and M. R. Rosen
Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium : I. In Vitro Study
Circulation, December 2, 1997; 96(11): 4011 - 4018.
[Abstract] [Full Text]

Home page
 CirculationHome page
P. Bailly, J.-P. Benitah, M. Mouchoniere, G. Vassort, and P. Lorente
Regional Alteration of the Transient Outward Current in Human Left Ventricular Septum During Compensated Hypertrophy
Circulation, August 19, 1997; 96(4): 1266 - 1274.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. F. Deng, S. Mulay, S. Chemtob, and D. R. Varma
Mechanisms of the Atrium-Specific Positive Inotropic Activities of Quinidine- and Atropine-Like Agents in Rats
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 322 - 329.
[Abstract] [Full Text]

Home page
 CirculationHome page
T. Yang and D. M. Roden
Extracellular Potassium Modulation of Drug Block of IKr : Implications for Torsade de Pointes and Reverse Use-Dependence
Circulation, February 1, 1996; 93(3): 407 - 411.
[Abstract] [Full Text]

Home page
 CirculationHome page
M. Nabauer, D. J. Beuckelmann, P. Uberfuhr, and G. Steinbeck
Regional Differences in Current Density and Rate-Dependent Properties of the Transient Outward Current in Subepicardial and Subendocardial Myocytes of Human Left Ventricle
Circulation, January 1, 1996; 93(1): 168 - 177.
[Abstract] [Full Text]

Home page
 CirculationHome page
P. Smits, S. B. Williams, D. E. Lipson, P. Banitt, G. A. Rongen, and M. A. Creager
Endothelial Release of Nitric Oxide Contributes to the Vasodilator Effect of Adenosine in Humans
Circulation, October 15, 1995; 92(8): 2135 - 2141.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online